FDA Approval of Bosulif Adds to Toolkit of Treatment Options for Children With CML
The Food and Drug Administration (FDA) has approved Bosulif (bosutinib) for the treatment of children as young as 1 year old with newly...
Oct 10, 2023
FDA approves dasatinib for children with Philadelphia chromosome-positive chronic myeloid leukemia
The FDA expanded the indication for dasatinib to include the treatment of children with Philadelphia chromosome-positive chronic myeloid...
Nov 13, 2017